Summary of major events in April

In April, the State Council, the national health and Family Planning Commission, the Ministry of human resources and social security, the Ministry of finance, CFDA and other departments issued policies and regulations frequently, and the industry rectification made it difficult for the pharmaceutical industry to continue to be happy: the national medical reform went to many places, the two vote system was implemented, and the one vote system was pilot in many places; the era of "affiliated" and "walking ticket" rectification came; the business tax was changed to value-added tax; the certificates of many companies that had passed the bill in Shandong vaccine case were revoked, and many companies had passed the bill Officials have been dealt with; the flight inspection of drug supervision has been strengthened unprecedentedly, and GMP certificates of many pharmaceutical enterprises have been withdrawn; the event of "Hong Kong Yinqiao antidote tablet" has put the historical problems of Chinese and Western medicine compound preparations on the hot search list; the evaluation of the consistency of generic drugs is even more joyous and sorrowful For more details, please pay attention to the drug intelligence policy and Regulations Database (http://db.yaozh.com/policies) The content of this article is the original of yaozhi.com If you need to reprint it, please indicate the source and the link address of this article If you have any infringement, you must be investigated for legal responsibility Thank you!